Literature DB >> 28984699

Emerging techniques in assessment and treatment of muscle tension dysphonia.

Meri L Andreassen1, Juliana K Litts, Derrick R Randall.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to summarize current evidence regarding treatment for muscle tension dysphonia (MTD) and to present recent advances in evaluation and management. RECENT
FINDINGS: It is generally accepted that voice therapy for MTD is effective, but current systematic reviews report limited evaluation specific to MTD patients with moderate evidence, at best, available to support voice therapy techniques. Individual studies are difficult to compare because of heterogeneity. Considerable work is underway to identify most important metrics to include in assessment, and to advance and define direct voice therapy approaches.
SUMMARY: Further standardization of assessment and treatment protocols for MTD will improve future research. Novel therapeutic techniques are under investigation. In small studies, these have found value in improving voice outcomes and measures compared with pretreatment values but have not met success greater than existing therapeutic methods.

Entities:  

Mesh:

Year:  2017        PMID: 28984699     DOI: 10.1097/MOO.0000000000000405

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  2 in total

1.  Injection laryngoplasty as adjunct treatment method for muscle tension dysphonia: Preliminary findings.

Authors:  Daniel Novakovic; Duong Duy Nguyen; Antonia Chacon; Catherine Madill
Journal:  Laryngoscope       Date:  2019-07-30       Impact factor: 3.325

2.  Estimation of Subglottal Pressure, Vocal Fold Collision Pressure, and Intrinsic Laryngeal Muscle Activation From Neck-Surface Vibration Using a Neural Network Framework and a Voice Production Model.

Authors:  Emiro J Ibarra; Jesús A Parra; Gabriel A Alzamendi; Juan P Cortés; Víctor M Espinoza; Daryush D Mehta; Robert E Hillman; Matías Zañartu
Journal:  Front Physiol       Date:  2021-09-01       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.